Focus on Myeloma
Helping Survivors Thrive after Marrow and Cord Blood Transplants
by Elizabeth A. Murphy, EdD, RN
Advances in transplant science have improved outcomes and have made transplant a viable treatment option for more people and a wider range of diseases.
Drug for Multiple Myeloma Demonstrated to Significantly Extend Disease-Free Survival
Initial results from a large, randomized clinical trial for people with multiple myeloma showed that people who received the oral drug lenalidomide (Revlimid, also known as CC-5013) following a blood stem cell transplant had their cancer kept in check longer than those who received a placebo.
Piecing Together Your Multiple Myeloma Treatment Options
Multiple myeloma is a type of cancer that begins in plasma cells (white blood cells that produce antibodies). Different types of treatments are available for people with multiple myeloma and other plasma cell neoplasms. Some treatments are standard, and some are being tested in clinical trials. Nine types of standard treatment for multiple myeloma are currently used.
